JAMES WALKER: Open Payments
NPI 1134149313 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 14 payments from 8 companies in 2025. Trend: 2023 $186 · 2024 $177 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Novo Nordisk Inc | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Amgen Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: VRAYLAR, AIRSUPRA, Ozempic, REXULTI, REPATHA, TRELEGY ELLIPTA, MOUNJARO, UBRELVY.
Industry payments across GA — which companies pay providers there.
